pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-136 |
Genomic Coordinates | chr14: 100884702 - 100884783 |
Description | Homo sapiens miR-136 stem-loop |
Comment | miR-136 was first identified by cloning studies in mouse . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-136-3p | ||||||||||||||||||||||||
Sequence | 49| CAUCAUCGUCUCAAAUGAGUCU |70 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | UBE3C | ||||||||||||||||||||
Synonyms | HECTH2 | ||||||||||||||||||||
Description | ubiquitin protein ligase E3C | ||||||||||||||||||||
Transcript | NM_014671 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on UBE3C | |||||||||||||||||||||
3'UTR of UBE3C (miRNA target sites are highlighted) |
>UBE3C|NM_014671|3'UTR 1 AGCTGATGCTGGGGTCAGACCCCTACAGAGAACCAGTGCTTCCTTCGTCAGCAGCGCCTCCCCAGACCCACGAGGATACT 81 CACACTGCACGCCTGAGGCTCTCCTAAGCTCCTTCTTTCATTCTGCCATTCCTCCCTCCCTTCCTTTTTTAAATGATTTT 161 TATTACGGTGTGGTCACTTATTTAGATGGACATTGCTTTTCAAATAACTTAAAATAACACGTTATGTGCCATGTGGCTAC 241 TTTAGTAATATTGCCAAGAAGAGCACAGTTTTTACACTAGTGGCATCTCAGTGAAATTAACCAAAGATGAAGCTTTGGCT 321 TTGCTGGTGAGATCAGAGCCCTCCTGAGCAGGCAGCGCCACTCCAGGGTTCAGACAGGGCTGCACAGGCGGCAGAGATAC 401 AGGGTCTGAGGGCTGAGACGCCATGGGGCCGCTGCTGCTTATGTGGTTGGATTGTTTACAAGCCTCATTATTAAAACTGA 481 AGGCATTTTTTTTTTCTGCTGCCTTTCCCAAAGTGGTTAGGTTTGGAAAAGAGATGATGATGGTAATATTTTATTTGTGC 561 TTTTTAAGCCATTTCCCCAAATGGGACTAGCATGCTTGTTTTCAGTATACCGTGGCCTGCCTCATGATGGTTTGGAGATA 641 CTGTCTGTGGATGTGAGGTGGGGACTTCATTCATTGTCCTATTTCTATCTCCACTTTGTGCCTGGAGAGCTTTCAGGGGA 721 GGTGGAGGAGGAGGGTCTGCCAAGCTACTGCAACATCTGTCACCCACTATACCCAGTTACTTGGGGGAGGACAGACACTG 801 TGGTGTCATTAAAGTTGTTTGAACCAAAGTGGCGGCTGCATCTTTGTCCCGATGCTAGCCGTGCCGGTCTCCCATCATCC 881 GCTCGCCCTCCTTTCCCCTGGGCTGCGCCCACTTGTCTTCCTGGATATTTGGGGGTGACTCGCCATGCTTGGCACCCTCT 961 GCTTCCTGGTGCTGCTCTGACTCGAAGACGGGACAGTCCCTGGTGCACATCCAGGGAAGAGGAGTGTCGGTAGTTCTTGC 1041 AGTAGGCACTTTATCAGGACCTGACCTGTTGCTGGGTGATTTTAGTCTCTACAAACAGAAAGCGTTTCAAAGCGTCAGCT 1121 GTGGGAGCAGAGTGACCCTTTGCTGATGCTGGGGGGAGGGGATCTAAATCCTCATTTATCTCTTCTATGTCTCGTATTTT 1201 ACTGTCACTGGAGGCTCTGTGGGCTGTCATAGTTAATTGACCATAATTAGCAATATACTTTTAAAGTGGGAAAGCTGAAT 1281 GACACTTTTAAGACAATGAACATTATCAAAACAAAATGTATAATTTCTTAATTTGAATAATAAATTAAGCGTTTAAATGC 1361 TATTTGTAGTCTTGATATACAGAAATAAAATAATTAGGGTTGGTCTTTTTTATTTTAGGTTGTTTTATGTTGAATGTTCT 1441 ATATCTTATTAGTTAATTTGTATATTTTATTAGTATTTTGGAAATAGCATATCTGAGACTGAAGAGAAATTGACAATTCA 1521 CTTATTTGTGGTTTTTTTCTCAGCTATTCTGAGCTTATTTATTTATTTGTATGTTCTAATGGCTAAACATTTACATTAAA 1601 TGTTTTTTTTCCCAAGAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | islets |
Tools used in this research | TargetScan |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in Supplenentary. RNA binding protein: AGO.
... - Kameswaran V; Bramswig NC; McKenna LB; Penn et al., 2014, Cell metabolism. |
Article |
- Kameswaran V; Bramswig NC; McKenna LB; Penn et al. - Cell metabolism, 2014
Type 2 diabetes mellitus (T2DM) is a complex disease characterized by the inability of the insulin-producing beta cells in the endocrine pancreas to overcome insulin resistance in peripheral tissues. To determine if microRNAs are involved in the pathogenesis of human T2DM, we sequenced the small RNAs of human islets from diabetic and nondiabetic organ donors. We identified a cluster of microRNAs in an imprinted locus on human chromosome 14q32 that is highly and specifically expressed in human beta cells and dramatically downregulated in islets from T2DM organ donors. The downregulation of this locus strongly correlates with hypermethylation of its promoter. Using HITS-CLIP for the essential RISC-component Argonaute, we identified disease-relevant targets of the chromosome 14q32 microRNAs, such as IAPP and TP53INP1, that cause increased beta cell apoptosis upon overexpression in human islets. Our results support a role for microRNAs and their epigenetic control by DNA methylation in the pathogenesis of T2DM.
LinkOut: [PMID: 24374217]
|
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
46 hsa-miR-136-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT256787 | CANX | calnexin | 1 | 1 | ||||||||
MIRT380416 | HNRNPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) | 1 | 1 | ||||||||
MIRT439175 | ZRANB1 | zinc finger RANBP2-type containing 1 | 1 | 1 | ||||||||
MIRT439356 | UBE3C | ubiquitin protein ligase E3C | 1 | 1 | ||||||||
MIRT439465 | TGFBR3 | transforming growth factor beta receptor 3 | 1 | 1 | ||||||||
MIRT440529 | GTF2F1 | general transcription factor IIF subunit 1 | 1 | 1 | ||||||||
MIRT440635 | FMN1 | formin 1 | 1 | 1 | ||||||||
MIRT440907 | COPS4 | COP9 signalosome subunit 4 | 1 | 1 | ||||||||
MIRT441019 | CAND1 | cullin associated and neddylation dissociated 1 | 1 | 1 | ||||||||
MIRT441061 | C1orf43 | chromosome 1 open reading frame 43 | 1 | 1 | ||||||||
MIRT441174 | ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 1 | 1 | ||||||||
MIRT456146 | RWDD2A | RWD domain containing 2A | 2 | 16 | ||||||||
MIRT483517 | PRPF38B | pre-mRNA processing factor 38B | 2 | 6 | ||||||||
MIRT483556 | STX11 | syntaxin 11 | 2 | 4 | ||||||||
MIRT495179 | SOX11 | SRY-box 11 | 2 | 6 | ||||||||
MIRT495184 | MUC20 | mucin 20, cell surface associated | 2 | 2 | ||||||||
MIRT499361 | MYLK | myosin light chain kinase | 2 | 8 | ||||||||
MIRT504160 | OPN5 | opsin 5 | 2 | 4 | ||||||||
MIRT523975 | DVL3 | dishevelled segment polarity protein 3 | 2 | 2 | ||||||||
MIRT524343 | CREBRF | CREB3 regulatory factor | 2 | 8 | ||||||||
MIRT526865 | PARP11 | poly(ADP-ribose) polymerase family member 11 | 2 | 2 | ||||||||
MIRT531887 | SCN1B | sodium voltage-gated channel beta subunit 1 | 2 | 2 | ||||||||
MIRT533351 | UHMK1 | U2AF homology motif kinase 1 | 2 | 2 | ||||||||
MIRT534099 | SOX5 | SRY-box 5 | 2 | 4 | ||||||||
MIRT557097 | HOXA9 | homeobox A9 | 2 | 2 | ||||||||
MIRT567000 | KLHL28 | kelch like family member 28 | 2 | 2 | ||||||||
MIRT568215 | C1orf21 | chromosome 1 open reading frame 21 | 2 | 2 | ||||||||
MIRT574254 | G6PC | glucose-6-phosphatase catalytic subunit | 2 | 2 | ||||||||
MIRT614013 | PAOX | polyamine oxidase | 2 | 2 | ||||||||
MIRT615541 | PHF1 | PHD finger protein 1 | 2 | 2 | ||||||||
MIRT622485 | REL | REL proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT623683 | HOXB6 | homeobox B6 | 2 | 2 | ||||||||
MIRT630575 | PLXDC2 | plexin domain containing 2 | 2 | 4 | ||||||||
MIRT642865 | FAM227A | family with sequence similarity 227 member A | 2 | 2 | ||||||||
MIRT649932 | TTLL7 | tubulin tyrosine ligase like 7 | 2 | 2 | ||||||||
MIRT654531 | RAB3GAP2 | RAB3 GTPase activating non-catalytic protein subunit 2 | 2 | 2 | ||||||||
MIRT656989 | KDM5A | lysine demethylase 5A | 2 | 2 | ||||||||
MIRT668527 | ERP44 | endoplasmic reticulum protein 44 | 2 | 2 | ||||||||
MIRT693411 | NUDT16 | nudix hydrolase 16 | 2 | 2 | ||||||||
MIRT700692 | POLR3D | RNA polymerase III subunit D | 2 | 2 | ||||||||
MIRT712284 | PPIP5K2 | diphosphoinositol pentakisphosphate kinase 2 | 2 | 2 | ||||||||
MIRT717286 | TRAF1 | TNF receptor associated factor 1 | 2 | 2 | ||||||||
MIRT724396 | IQGAP1 | IQ motif containing GTPase activating protein 1 | 2 | 2 | ||||||||
MIRT725201 | PTRF | caveolae associated protein 1 | 2 | 2 | ||||||||
MIRT731933 | NOTCH3 | notch 3 | 2 | 1 | ||||||||
MIRT756476 | BMPR1B | bone morphogenetic protein receptor type 1B | 3 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|